Clinical Impact of New Data From AASLD 2019

November 8-12, 2019; Boston, Massachusetts
This downloadable slideset reviews new, clinically relevant data on viral hepatitis and NAFLD/NASH; topics include risk of HCC in patients with viral hepatitis, HBV and HCV treatment, organ transplant from donors with HCV infection, and novel treatments for NAFLD/NASH.
Ira M. Jacobson, MD
Nancy Reau, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 894 KB
Released: December 2, 2019


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Related Content

下载由专家编写的免费幻灯片,了解亚太地区关于乙型肝炎环境中 HCC 的考虑的最新信息。

Grace LH Wong, 医学博士 Released: June 18, 2021

B 型肝炎の状況における HCC のリスクに関する、アジア太平洋地域における考慮点について、最新情報を得るために、専門家が作成した無料スライドをダウンロード

Grace LH Wong, MDは Released: June 18, 2021

Download free expert-authored slides to get up-to-date on Asia-Pacific considerations regarding HCC in the setting of hepatitis B.

Grace LH Wong, MD Released: June 10, 2021

Clinical Care Options (CCO) expert Dr Grace LH Wong discusses Asia-Pacific considerations in caring for patients with HBV at risk for HCC

Grace LH Wong, MD Released: June 8, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.